Drawing for RETROMETABOLIC DRUG DESIGN

USPTO serial 78831505

RETROMETABOLIC DRUG DESIGN

Reviewed by CopyMark Law Group

Reg. 3266793Status 713
Filing date
Status date
Registration date
Jul 17, 2007
Examiner
FINE, STEVEN
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RETROMETABOLIC DRUG DESIGN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James M. McCarthy

Aryx Therapeutics, Inc.6300 Dumbarton CircleFremont, CA 94555UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Medicinal and biological product research, development, and testingSECTION 18 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 3, 2008C18.CANCELLED SECTION 18-TOTAL—
Dec 3, 2008CANTCANCELLATION TERMINATED NO. 999999—
Nov 21, 2008CANGCANCELLATION GRANTED NO. 999999—
Jun 17, 2008PETCCANCELLATION INSTITUTED NO. 999999—
Jul 17, 2007R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
May 4, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 4, 2007CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
May 4, 2007IUAAUSE AMENDMENT ACCEPTED—
May 4, 2007XAECEXAMINER'S AMENDMENT ENTERED—
May 4, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
May 4, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 6, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Apr 6, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2007AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Apr 6, 2007ALIEASSIGNED TO LIE—
Mar 5, 2007MAILPAPER RECEIVED—
Mar 2, 2007IUAFUSE AMENDMENT FILED—
Mar 2, 2007EAAUTEAS AMENDMENT OF USE RECEIVED—
Sep 2, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 2, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2006DOCKASSIGNED TO EXAMINER—
Mar 15, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance